Printer Friendly

Cardiac Biomarkers Market Growing at 12.75% CAGR to 2018.

DALLAS, November 10, 2014 /PRNewswire/ -- adds Global Cardiac Biomarkers Market 2014-2018 research report of 105 pages to its online industry intelligence and business data library. This research forecasts the Global Cardiac Biomarkers market to grow at a CAGR of 12.75% over the period 2013-2018. Complete report is available at

This report covers the present scenario and the growth prospects of the Global Cardiac Biomarkers market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of devices and assays used for cardiac biomarkers to diagnose various cardiovascular diseases. A cardiac biomarker is defined as a measurable substance that is an indicator used in the diagnosis and risk stratification related to cardiovascular disease (CVDs) such as acute coronary syndrome (ACS), coronary syndromes, myocardial infarction (MI), and heart failure. Some of the cardiac biomarkers include creatine kinase (CK) MB, troponins (cTnI and cTnT), BNP, NT-proBNP, GFAP, H-FABP, LDH isoenzymes, D-dimer, IMA, MPO, myoglobin, and sCD40L. Cardiac biomarker assays help medical professionals to understand and differentiate between myocardial infarction and angina, which assists in the diagnosis and treatment of CVDs. The abnormal concentration of these biomarkers will act as significant predictors of an adverse cardiovascular condition. Cardiac point of care (POC) testing offers reliable measurement of cardiac biomarkers and provides results within one hour of testing. In addition to saving time, some cardiac POC tests have been modified to improve the accuracy of the measurement of enzymes to reduce operational error.

The cardiac biomarkers market is segmented based on the following types of assays: Troponin (cTnI and cTnT), BNP & NT-proBNP, CK-MB, Myogloblin and Others (hs-CRP, D-Dimer, GFAP, H-FABP, LDH isoenzymes, D-dimer, IMA, MPO, myoglobin, AST, FFAu, and sCD40L). The Global Cardiac Biomarkers Market 2014-2018 research report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Cardiac Biomarkers market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Companies discussed in the cardiac biomarkers market report with forecasts to 2018 include Abbott Laboratories, Alere, Ortho Clinical Diagnostics, Roche Diagnostics, AniBiotech, Axis-Shield, Beckman Coulter, Becton, Dickinson and Co., BG Medicine, Biomerieux, Boston Scientific, Critical Diagnostics, diaDexus, LifeSign, Mitsubishi Chemical Europe, Nanomix, Radiometer Medical, Randox Laboratories, Response Biomedical, Siemens Healthcare, Sierra Resources International, Singulex, Thermo Scientific and Trinity Biotech. Order a copy of this research at This report and its market analysis is supported with 63 exhibits on the industry and its players.

Biomarker Partnering Terms and Agreements is another research of 1048 pages that provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the world's leading healthcare companies. This report contains over 700 links to online copies of actual biomarker deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal. In addition, a comprehensive appendix is provided organized by biomarker partnering company A-Z, stage of development, deal type, therapy area, deal type definitions and biomarker partnering agreements example. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of biomarker technologies and products. Complete report is available at

The Global Cardiac POC Market 2014-2018 research report forecasts the cardiac POC industry to grow at 14.40% CAGR to 2018. Cardiac POC is a medical test performed near to the site of the patient. The Cardiac POCs are simple medical blood tests that include cholesterol and coagulation testing. Cardiac POC tests include Troponin and brain natriuretic peptide tests, which are used to diagnose cardiovascular conditions such as acute myocardial infarction, coronary syndromes and heart failure. These tests help in the detection of enzymes released during failure of the heart and in critical cardiac conditions such as creating kinase, troponin, lactate dehydrogenase isoenzymes and brain natriuretic peptides. The Cardiac POC tests helps to understand and differentiate better between myocardial infarction and angina, which help to diagnose the patient for a specific disease. These tests or assays offer reliable measurement of the markers, released during heart failure, and provide results within one hour of testing. In addition, to save time, a few Cardiac POC tests have been modified to measure enzymes to reduce operational error and simplify performance. Thus, these tests help significantly in reducing the turnaround time from testing to end results by allowing immediate patient response and effective treatment, or the discharge of patients. To calculate the market size, the report considers revenue generated from the sales of two type of tests: Troponin and brain natriuretic peptide tests, which are used to treat Cardiac POC. Furthermore, the report considers revenue generated from the following type of tests - Biosite Triage, Cobas and i-STAT. The report also presents the vendor landscape and a corresponding detailed analysis of the top three vendors in the Global Cardiac POC market. In addition, it discusses the major drivers that influence the growth of the Global Cardiac POC market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market. Companies like Alere Inc., Abbott Laboratories, Roche Diagnostics, Beckman Coulter, Inc., BG Medicine Inc., Boston Scientific Corp, Medtronic Inc. and Randox Laboratories Ltd. are discussed in this research available at

Explore more reports on the biotechnology market at and the overall healthcare industry at

About Us: is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.


Ritesh Tiwari

TX, Dallas North - Dominion Plaza, 17304, Preston Road, Suite 800, Dallas 75252

Tel: +1-888-391-5441

Connect With Us on:

Facebook: https: //


Twitter: https: //


RSS/Feeds: http: //
COPYRIGHT 2014 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire Europe
Date:Nov 10, 2014
Previous Article:Global Biochips and Microarrays 2014 - Technologies, Markets, Companies and Forecasts to 2023.
Next Article:Christopher Nolan's "Interstellar" Lifts off in the UK With [pounds sterling]5,377,527 Debut.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters